These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19499272)

  • 1. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.
    Yuksel N; Majumdar SR; Biggs C; Tsuyuki RT
    Osteoporos Int; 2010 Mar; 21(3):391-8. PubMed ID: 19499272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of bone mineral density testing in patients at high risk of osteoporosis: secondary analyses from the OSTEOPHARM randomized trial.
    Yuksel N; Tsuyuki RT; Majumdar SR
    J Clin Densitom; 2012; 15(1):61-6. PubMed ID: 22071024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.
    Majumdar SR; Johnson JA; Bellerose D; McAlister FA; Russell AS; Hanley DA; Garg S; Lier DA; Maksymowych WP; Morrish DW; Rowe BH
    Osteoporos Int; 2011 Jan; 22(1):223-30. PubMed ID: 20358359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.
    Salvig BE; Gulum AH; Walters SA; Edwards LB; Fourakre TN; Marvin SC; McKenzie MS; Moseley MV; Ansari IJ
    Consult Pharm; 2016; 31(8):440-9. PubMed ID: 27535079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and feasibility of a community pharmacy bone mineral density screening and education program.
    Cerulli J; Zeolla MM
    J Am Pharm Assoc (2003); 2004; 44(2):161-7. PubMed ID: 15098850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial.
    Majumdar SR; Johnson JA; McAlister FA; Bellerose D; Russell AS; Hanley DA; Morrish DW; Maksymowych WP; Rowe BH
    CMAJ; 2008 Feb; 178(5):569-75. PubMed ID: 18299546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
    Angthong C; Rodjanawijitkul S; Samart S; Angthong W
    Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis screening and education in community pharmacies using a team approach.
    MacLaughlin EJ; MacLaughlin AA; Snella KA; Winston TS; Fike DS; Raehl CR
    Pharmacotherapy; 2005 Mar; 25(3):379-86. PubMed ID: 15843285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial.
    Heyworth L; Kleinman K; Oddleifson S; Bernstein L; Frampton J; Lehrer M; Salvato K; Weiss TW; Simon SR; Connelly M
    Osteoporos Int; 2014 May; 25(5):1519-26. PubMed ID: 24566584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
    Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
    Trials; 2015 May; 16():214. PubMed ID: 25962885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis.
    Naunton M; Peterson GM; Jones G
    Ann Pharmacother; 2006 Jan; 40(1):38-44. PubMed ID: 16303984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacist-led community bone mineral density screenings.
    Summers KM; Brock TP
    Ann Pharmacother; 2005 Feb; 39(2):243-8. PubMed ID: 15613465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies.
    Johnson JF; Koenigsfeld C; Hughell L; Parsa RA; Bravard S
    J Am Pharm Assoc (2003); 2008; 48(3):379-87. PubMed ID: 18595823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions.
    Kalisch Ellett LM; Pratt NL; Sluggett JK; Ramsay EN; Kerr M; LeBlanc VT; Barratt JD; Roughead EE
    Arch Osteoporos; 2017 Dec; 12(1):17. PubMed ID: 28188561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
    Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
    Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the fracture risk assessment on patient and physician behavior in osteoporosis prevention.
    McConaha JL; Berdine HJ; Skomo ML; Laux RV; Higginbotham SK; O'Neil CK
    J Pharm Pract; 2014 Feb; 27(1):25-30. PubMed ID: 24108433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Beaton DE; Vidmar M; Pitzul KB; Sujic R; Rotondi NK; Bogoch ER; Sale JEM; Jain R; Weldon J
    Osteoporos Int; 2017 Mar; 28(3):863-869. PubMed ID: 27770155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial.
    Jaglal SB; Donescu OS; Bansod V; Laprade J; Thorpe K; Hawker G; Majumdar SR; Meadows L; Cadarette SM; Papaioannou A; Kloseck M; Beaton D; Bogoch E; Zwarenstein M
    Osteoporos Int; 2012 Jan; 23(1):87-95. PubMed ID: 21779817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.